Annika M. Bruger

438 citations
9 papers · 303 indexed · h-index 7
Topics
Immune cells in cancer (5 papers)Immune Cell Function and Interaction (3 papers)Immune Response and Inflammation (2 papers)
Partner nations
BelgiumFranceGermany

In The Last Decade

Annika M. Bruger

9 papers receiving 300 citations

Peers

Annika M. Bruger
Comparison fields: 5 of 56
  • Immunology 254
  • Oncology 92
  • Molecular Biology 75
  • Neurology 19
  • Cancer Research 16
Replace Zhong-Min Wang with:
Zhong-Min Wang United States
Sharareh Bordbari Germany
Hristo Georgiev Germany
Jasmin Grählert Switzerland
Barbara Höllbacher United States
Kerstin Westendorf Germany
Amir Ferry United States
Irene Mattiola Germany
Geraldine Rühl Germany
Lauren K. Quezada United States
Annika M. Bruger relative to Zhong-Min Wang United States Zhong-Min Wang's profile →
Citations per field
00.5×6.8×
Zhong-Min Wang · 1×
Citations per year

Countries citing papers authored by Annika M. Bruger

Since Specialization
Citations

This map shows the geographic impact of Annika M. Bruger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika M. Bruger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika M. Bruger more than expected).

Fields of papers citing papers by Annika M. Bruger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika M. Bruger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika M. Bruger. The network helps show where Annika M. Bruger may publish in the future.

Co-authorship network of co-authors of Annika M. Bruger

This figure shows the co-authorship network connecting the top 25 collaborators of Annika M. Bruger. A scholar is included among the top collaborators of Annika M. Bruger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika M. Bruger. Annika M. Bruger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 14
2 3
3 12
4 56
5 1
6 20
7 107
8 24
9 66

About Annika M. Bruger

Annika M. Bruger is a scholar working on Immunology, Obstetrics and Gynecology and Reproductive Medicine, having authored 9 papers that have together received 303 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Immune Cell Function and Interaction (3 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (254 citations), Oncology (92 citations) and Neurology (19 citations). Annika M. Bruger has collaborated with scholars based in Belgium, France and Germany. Frequent co-authors include Pierre van der Bruggen, Güneş Esendağlı, Sven Brandau, Jo A. Van Ginderachter, Tomáš Perečko, Margarida Saraiva, Katarzyna Barczyk‐Kahlert, Anca Dorhoi, Marie Lipoldová and Juan F. Santibáñez. Their work appears in journals such as The EMBO Journal, Blood and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026